89bio, Inc. Marketable Securities (Current)
89bio, Inc. had Marketable Securities (Current) of $432.09 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2025-08-08
- 2025-06-30: Marketable Securities, Current $432.09M.
- 2025-03-31: Marketable Securities, Current $323.38M.
- 2024-12-31: Marketable Securities, Current $313.89M.
- 2024-09-30: Marketable Securities, Current $332.36M.
| Period end | Marketable Securities, Current |
|---|---|
| 2025-06-30 | $432.09M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $323.38M 10-Q · filed 2025-05-02 |
| 2024-12-31 | $313.89M 10-Q · filed 2025-08-08 |
| 2024-09-30 | $332.36M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $319.17M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $344.71M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $262.71M 10-K · filed 2025-02-27 |
| 2022-12-31 | $132.91M 10-K · filed 2024-03-01 |